HOME >> BIOLOGY >> NEWS
ANU medical researcher wins national award

ANU immunologist Professor Chris Goodnow has been awarded the Commonwealth Health Minister's Award for Excellence in Health and Medical Research for his research in molecular genetics.

Professor Goodnow, the Director of the Australian Phenomics Facility and Head of the Medical Genome Centre at the John Curtin School of Medical Research, said the award recognised a forward-looking medical research program underway at ANU based on a 'roadmap' of the human genome.

"I'm thrilled to have received this prestigious award from the Australian Government - it is not only satisfying for me personally, but it also is added confirmation of a bold strategy being undertaken at ANU to discover the mechanisms of immune regulation," Professor Goodnow said.

"The next decade of medical science will be driven by investigation of the genome sequence, and research at the John Curtin School of Medical Research is already focusing on this area."

Professor Goodnow said that the Federal Government-funded Australian Phenomics Facility will be a driving force in this genome research, with its program for screening hundreds of thousands of gene sequences and making them accessible to medical researchers around the world.

It has already led to a number of breakthroughs at ANU in one of the largest health problems in the community - dysfunction of the immune system. Autoimmune diseases include type 1 diabetes, rheumatoid arthritis, systemic lupus and multiple sclerosis.

"The research program is a clear example of how ANU leads Australian and international research by looking over the horizon and starting new research fields in anticipation of future of developments - in this case anticipating the sequence of the human genome.

"This current work lays out a genetic roadmap for developing ways to prevent or cure diabetes and other autoimmune diseases, which collectively affect one in 20 Australians.

"It looks into genes and gene mechanis
'"/>

Contact: Tim Winkler
tim.winkler@anu.edu.au
61-2-6125-5001
Research Australia
10-Jun-2005


Page: 1 2

Related biology news :

1. New proteomics research promises to revolutionize biomedical discovery
2. New medical implants should react with the body, not seek to be inert
3. Bee researcher at Arizona State University is 1 of 20 new Pew Scholars in the biomedical sciences
4. Methodist, University of Houston, Cornell combine biomedical imaging expertise
5. Research center unites biomedical competitors to fund medical technology development
6. FSU researchers reap $1-million grant to make medical implants safer
7. New Arizona alliance aims to boost technologies for medical diagnostics and human health
8. Yale biophysicist Thomas Steitz receives Gairdner Award for medical research
9. DNA sequence of Rhesus macaque has evolutionary, medical implications
10. 4th International Conference on Ethical Issues in Biomedical Engineering
11. UT Metroplex institutions to collaborate on biomedical research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ANU medical researcher wins national award

(Date:1/22/2015)... 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) ... Global Market Overview" report to their offering. , ... ensure that an individual is who she/he is claiming to ... of a person,s unique physical characteristics, such as fingerprint, hand ...
(Date:1/22/2015)... FindBiometrics, the leading source of biometrics industry news, interviews and ... "When we launched FindBiometrics 12 years ago the ... founder and CEO of FindBiometrics. "Now it,s maturing very quickly. ... players on a very broad scale.  We are known for ...
(Date:1/22/2015)... Showcase, Hall E -   EyeLock Inc. , a market ... showcase its EyeLock ID technology integrated in a 3D printed ... Oak Ridge National Laboratory (ORNL) at the 2015 ... technology is being used to validate the driver and authorize ...
Breaking Biology News(10 mins):Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
(Date:3/4/2015)... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... , 3.75% Convertible Senior Notes due May 1, ... per $1,000 principal amount or approximately $5.72 per share, effective ... note is adjusted in connection with the regular quarterly dividend ... stockholders who own shares of PDL on March 5, 2015, the ...
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/nqxxt3/biomarkers ) ... report "Biomarkers - Technologies, Markets and Companies" ... report follows the broad definition of a biomarker ... and evaluated as an indicator of normal biological ... to a therapeutic intervention. Tests based on biomarkers ...
(Date:3/4/2015)... , March 4, 2015 AcelRx ... specialty pharmaceutical company focused on the development and ... acute and breakthrough pain, today announced that it ... results after market close on Monday, March 9th, ... call at 4:30 p.m. Eastern Time (1:30 p.m. ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
Breaking Biology Technology:PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6
Cached News: